This covers the clinical evidence and rationale for focal dose escalation to the MRI-defined GTV in prostate cancer. We will also review real clinical cases to learn the best way to identify the GTV and contour for radiotherapy planning. Dosimetric constraints and pitfalls will be considered.
This webinar was sponsored by the ROI Juan A. del Regato Fund. The ROI is ASTRO’s Research Foundation and more information can be found at roinstitute.org.
This activity is available from October 19, 2023, through 11:59 p.m. Eastern time on October 18, 2025.
TARGET AUDIENCE
This course is designed to meet the interest of radiation oncologists and radiation oncology residents.
LEARNING OBJECTIVES
Upon completion of this live activity, participants should be able to:
Describe the patient cohort most likely to benefit from a focal boost to the prostate.
Have a framework for assessing multiparametric prostate MRIs for the purposes of defining a boost.
Practice boost delineation with the opportunity for peer feedback.
Reviews
There are no reviews yet.